These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 15066950)
1. Inhibition of phosphodiesterase type 5 by the activator of nitric oxide-sensitive guanylyl cyclase BAY 41-2272. Mullershausen F; Russwurm M; Friebe A; Koesling D Circulation; 2004 Apr; 109(14):1711-3. PubMed ID: 15066950 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle. Toque HA; Mónica FZ; Morganti RP; De Nucci G; Antunes E Eur J Pharmacol; 2010 Oct; 645(1-3):158-64. PubMed ID: 20670622 [TBL] [Abstract][Full Text] [Related]
4. In vivo reconstitution of the negative feedback in nitric oxide/cGMP signaling: role of phosphodiesterase type 5 phosphorylation. Mullershausen F; Russwurm M; Koesling D; Friebe A Mol Biol Cell; 2004 Sep; 15(9):4023-30. PubMed ID: 15240816 [TBL] [Abstract][Full Text] [Related]
5. High and low gain switches for regulation of cAMP efflux concentration: distinct roles for particulate GC- and soluble GC-cGMP-PDE3 signaling in rabbit atria. Wen JF; Cui X; Jin JY; Kim SM; Kim SZ; Kim SH; Lee HS; Cho KW Circ Res; 2004 Apr; 94(7):936-43. PubMed ID: 14988225 [TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms underlying rat mesenteric artery vasorelaxation induced by the nitric oxide-independent soluble guanylyl cyclase stimulators BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-4-ylamine] and YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl Indazole]. Teixeira CE; Priviero FB; Webb RC J Pharmacol Exp Ther; 2006 Apr; 317(1):258-66. PubMed ID: 16352702 [TBL] [Abstract][Full Text] [Related]
7. Desensitization of NO/cGMP signaling in smooth muscle: blood vessels versus airways. Mullershausen F; Lange A; Mergia E; Friebe A; Koesling D Mol Pharmacol; 2006 Jun; 69(6):1969-74. PubMed ID: 16510560 [TBL] [Abstract][Full Text] [Related]
8. Activators and stimulators of soluble guanylate cyclase counteract myofibroblast differentiation of prostatic and dermal stromal cells. Zenzmaier C; Kern J; Heitz M; Plas E; Zwerschke W; Mattesich M; Sandner P; Berger P Exp Cell Res; 2015 Nov; 338(2):162-9. PubMed ID: 26410556 [TBL] [Abstract][Full Text] [Related]
9. BAY 41-2272 activates two isoforms of nitric oxide-sensitive guanylyl cyclase. Koglin M; Stasch JP; Behrends S Biochem Biophys Res Commun; 2002 Apr; 292(4):1057-62. PubMed ID: 11944922 [TBL] [Abstract][Full Text] [Related]
10. Cyclic GMP and cGMP-binding phosphodiesterase are required for interleukin-1-induced nitric oxide synthesis in human articular chondrocytes. Geng Y; Zhou L; Thompson WJ; Lotz M J Biol Chem; 1998 Oct; 273(42):27484-91. PubMed ID: 9765278 [TBL] [Abstract][Full Text] [Related]
11. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation. Nimmegeers S; Sips P; Buys E; Brouckaert P; Van de Voorde J Cardiovasc Res; 2007 Oct; 76(1):149-59. PubMed ID: 17610859 [TBL] [Abstract][Full Text] [Related]
12. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease. Boerrigter G; Burnett JC Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the relaxant effect of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in isolated detrusor smooth muscle. Báu FR; Mónica FZ; Priviero FB; Baldissera L; de Nucci G; Antunes E Eur J Pharmacol; 2010 Jul; 637(1-3):171-7. PubMed ID: 20399768 [TBL] [Abstract][Full Text] [Related]
14. Stimulation of soluble guanylyl cyclase by BAY 41-2272 relaxes anococcygeus muscle: interaction with nitric oxide. Teixeira CE; Priviero FB; Claudino MA; Baracat JS; De Nucci G; Webb RC; Antunes E Eur J Pharmacol; 2006 Jan; 530(1-2):157-65. PubMed ID: 16371226 [TBL] [Abstract][Full Text] [Related]
15. Effects of BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase, on human NADPH oxidase system from THP-1 cells. Borges de Oliveira-Junior E; Thomazzi SM; Rehder J; Antunes E; Condino-Neto A Eur J Pharmacol; 2007 Jul; 567(1-2):43-9. PubMed ID: 17499238 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of relaxation and interaction with nitric oxide of the soluble guanylate cyclase stimulator BAY 41-2272 in mouse gastric fundus and colon. Cosyns SM; Lefebvre RA Eur J Pharmacol; 2012 Jul; 686(1-3):104-15. PubMed ID: 22575520 [TBL] [Abstract][Full Text] [Related]
18. Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis. Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H Kidney Int; 2005 Jul; 68(1):47-61. PubMed ID: 15954895 [TBL] [Abstract][Full Text] [Related]
19. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis. Peters H; Wang Y; Loof T; Martini S; Kron S; Krämer S; Neumayer HH Kidney Int; 2004 Dec; 66(6):2224-36. PubMed ID: 15569311 [TBL] [Abstract][Full Text] [Related]
20. Sildenafil potentiates nitric oxide mediated inhibition of human platelet aggregation. Gudmundsdóttir IJ; McRobbie SJ; Robinson SD; Newby DE; Megson IL Biochem Biophys Res Commun; 2005 Nov; 337(1):382-5. PubMed ID: 16185664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]